Table 3.
A, Performance of STONE score for symptomatic stone on CT with and without renal PLUS. | |||||||
---|---|---|---|---|---|---|---|
| |||||||
STONE Score | Finding on Renal PLUS | Symptomatic Stone on CT | Se (95% CI) | Sp (95% CI) | LR+ (95% CI) | LR- (95% CI) | |
| |||||||
Yes | No | ||||||
All patients (n = 835) | |||||||
Without PLUS | 442 | 393 | NA | NA | NA | NA | |
Any hydro | 288 | 98 | 65 (61-70) | 75 (71-79) | 2.6 (2.1-3.1) | 0.46 (0.41-0.53) | |
Moderate of greater | 123 | 23 | 44 (38-51) | 93 (89-95) | 6.1 (4.1-9.3) | 0.60 (0.54-0.67) | |
Low (n = 144) | |||||||
Without PLUS | 14 | 130 | 3.2 (1.7-5.3) | 67 (62-72) | 0.1 (0.06-0.16) | 1.5 (1.4-1.6) | |
Any hydro | 9 | 17 | 64 (36-86) | 87 (80-92) | 4.9 (2.7-8.9) | 0.41 (0.2-0.83) | |
Moderate or greater | 3 | 2 | 38 (10-74) | 98 (93-99) | 21.6 (4.2-111) | 0.64 (0.37-1.1) | |
Moderate (n = 411) | |||||||
Without PLUS | 183 | 228 | 41 (37-46) | 42 (37-47) | 0.71 (0.62-0.82) | 1.4 (1.2-1.6) | |
Any hydro | 109 | 67 | 60 (52-67) | 71 (64-76) | 2.0 (1.6-2.6) | 0.57 (0.48-0.69) | |
Moderate or greater | 53 | 15 | 42 (36-48) | 92 (86-95) | 4.9 (2.9-8.3) | 0.64 (0.55-0.74) | |
High (n = 280) | |||||||
Without PLUS | 245 | 35 | 55 (51-60) | 91 (88-94) | 6.2 (4.5-8.6) | 0.49 (0.44-0.55) | |
Any hydro | 170 | 14 | 69 (63-75) | 60 (42-76) | 1.7 (1.1-2.6) | 0.51 (0.41-0.64) | |
Moderate or greater | 67 | 6 | 47 (39-56) | 78 (57-91) | 2.1 (1.0-4.4) | 0.68 (0.57-0.81) | |
| |||||||
B, Performance of STONE score for urologic intervention with and without renal PLUS. | |||||||
| |||||||
Urologic Intervention | |||||||
|
|||||||
STONE Score | Finding on Renal PLUS | Yes | No | Se (95% CI) | Sp (95% CI) | LR+ (95% CI) | LR- (95% CI) |
| |||||||
All patients (n = 835) | |||||||
Without PLUS | 113 | 702 | NA | NA | NA | NA | |
Any hydro | 88 | 298 | 66 (57-74) | 58 (54-61) | 1.6 (1.3-1.8) | 0.59 (0.46-0.75) | |
Moderate or greater | 48 | 98 | 36 (28-45) | 86 (83-89) | 2.6 (1.9-3.5) | 0.74 (0.65-0.84) | |
Low (n = 144) | |||||||
Without PLUS | 9 | 135 | 6.7 (3.3-13) | 81 (78-84) | 0.35 (0.18-0.67) | 1.1 (1.1-1.2) | |
Any hydro | 4 | 22 | 44 (15-77) | 84 (76-89) | 2.7 (1.2-6.2) | 0.66 (0.37-1.2) | |
Moderate or greater | 3 | 2 | 33 (9-69) | 99 (94-99) | 23 (4.3-117) | 0.68 (0.43-1.1) | |
Moderate (n = 411) | |||||||
Without PLUS | 65 | 346 | 49 (40-58) | 51 (47-55) | 0.99 (0.82-1.2) | 1.0 (0.85-1.2) | |
Any hydro | 36 | 140 | 55 (43-68) | 60 (54-65) | 1.4 (1.1-1.8) | 0.75 (0.57-0.98) | |
Moderate or greater | 19 | 49 | 29 (19-42) | 86 (82-89) | 2.1 (1.3-3.3) | 0.82 (0.7-0.96) | |
High (n = 280) | |||||||
Without PLUS | 59 | 221 | 44 (36-53) | 69 (65-72) | 1.4 (1.1-1.8) | 0.81 (0.7-0.95) | |
Any hydro | 48 | 136 | 81 (69-90) | 39 (32-45) | 1.3 (1.1-1.6) | 0.48 (0.28-0.84) | |
Moderate or greater | 26 | 47 | 44 (31-58) | 79 (73-84) | 2.1 (1.4-3) | 0.71 (0.57-0.89) |
Hydro, Hydronephrosis; Se, sensitivity; Sp, specificity; LR+, positive likelihood ratio; LR−, negative likelihood ratio.